These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24507068)

  • 41. Women and transplantation: fertility, sexuality, pregnancy, contraception.
    Josephson MA; McKay DB
    Adv Chronic Kidney Dis; 2013 Sep; 20(5):433-40. PubMed ID: 23978550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary alveolar proteinosis in a kidney transplant: a rare complication of sirolimus.
    Kadikoy H; Paolini M; Achkar K; Suki W; Gaber AO; Anwar N; Jeroudi A; Barrios R; Abdellatif A
    Nephrol Dial Transplant; 2010 Aug; 25(8):2795-8. PubMed ID: 20484303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pregnancies following kidney transplantation--clinical problems and genetic studies].
    Koall W; Müller R
    Z Gesamte Inn Med; 1988 Sep; 43(17):479-84. PubMed ID: 3070974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gonadal impact of target of rapamycin inhibitors (sirolimus and everolimus) in male patients: an overview.
    Huyghe E; Zairi A; Nohra J; Kamar N; Plante P; Rostaing L
    Transpl Int; 2007 Apr; 20(4):305-11. PubMed ID: 17326771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recommendations for use of Certican (everolimus) after heart transplantation: results from a German and Austrian Consensus Conference.
    Hummel M
    J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S196-200; discussion S210-1. PubMed ID: 15774322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial.
    Dantal J; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Quéré S; Di Giambattista F; Cassuto E;
    Transpl Int; 2010 Nov; 23(11):1084-93. PubMed ID: 20500493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients: an echocardiographic substudy of the randomized controlled CENTRAL trial.
    Murbraech K; Holdaas H; Massey R; Undset LH; Aakhus S
    Transplantation; 2014 Jan; 97(2):184-8. PubMed ID: 24092385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conversion to everolimus in kidney transplant recipients: a safe and simple procedure.
    Ruiz JC; Sanchez-Fructuoso A; Rodrigo E; Conesa J; Cotorruelo JG; Gómez-Alamillo C; Calvo N; Barrientos A; Arias M
    Transplant Proc; 2006 Oct; 38(8):2424-6. PubMed ID: 17097956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Late Pulmonary Toxicity Associated With Everolimus in a Renal Transplant Patient and Review of the Literature.
    Velioglu A; Eryuksel E; Cimsit C; Tuglular S; Ozener C
    Exp Clin Transplant; 2018 Aug; 16(4):491-494. PubMed ID: 27001620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pregnancy after kidney transplantation: two transplantation centers--Vicenza-Udine experience.
    Di Loreto P; Martino F; Chiaramonte S; Dissegna D; Ronco C; Marchesoni D; Catapano P; Romano G; Montanaro D
    Transplant Proc; 2010 May; 42(4):1158-61. PubMed ID: 20534249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pregnancy after kidney transplantation : the Erasme Hospital experience].
    Deroover Y; Wissing KM; Kirkpatrick C
    Rev Med Brux; 2007; 28(2):83-90. PubMed ID: 17561722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients.
    Celik S; Doesch A; Erbel C; Blessing E; Ammon K; Koch A; Katus HA; Dengler TJ
    Transplantation; 2008 Jul; 86(2):245-50. PubMed ID: 18645486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclosporine versus everolimus: effects on the glomerulus.
    Baas MC; Kers J; Florquin S; de Fijter JW; van der Heide JJ; van den Bergh Weerman MA; ten Berge IJ; Bemelman FJ
    Clin Transplant; 2013; 27(4):535-40. PubMed ID: 23795805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pregnancy in women with chronic renal disease.
    Hou S
    N Engl J Med; 1985 Mar; 312(13):836-9. PubMed ID: 3883174
    [No Abstract]   [Full Text] [Related]  

  • 55. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resolution of sirolimus-induced pneumonitis after conversion to everolimus.
    Rehm B; Keller F; Mayer J; Stracke S
    Transplant Proc; 2006 Apr; 38(3):711-3. PubMed ID: 16647451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of combination therapy with everolimus and sorafenib for recurrence of hepatocellular carcinoma after liver transplantation.
    De Simone P; Crocetti L; Pezzati D; Bargellini I; Ghinolfi D; Carrai P; Leonardi G; Della Pina C; Cioni D; Pollina L; Campani D; Bartolozzi C; Lencioni R; Filipponi F
    Transplant Proc; 2014; 46(1):241-4. PubMed ID: 24507059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Everolimus in clinical practice in long-term liver transplantation: an observational study.
    Casanovas T; Argudo A; Peña-Cala MC
    Transplant Proc; 2011; 43(6):2216-9. PubMed ID: 21839237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature.
    Nashan B; Citterio F
    Transplantation; 2012 Sep; 94(6):547-61. PubMed ID: 22941182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity.
    Haidinger M; Hecking M; Weichhart T; Poglitsch M; Enkner W; Vonbank K; Prayer D; Geusau A; Oberbauer R; Zlabinger GJ; Soleiman A; Hörl WH; Säemann MD
    Transpl Int; 2010 Aug; 23(8):777-85. PubMed ID: 20070623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.